{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:26:18Z","timestamp":1785403578649,"version":"3.56.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007959","name":"Chulabhorn Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007959","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012309","name":"Royal Golden Jubilee","doi-asserted-by":"publisher","award":["PHD\/0181\/2559"],"award-info":[{"award-number":["PHD\/0181\/2559"]}],"id":[{"id":"10.13039\/501100012309","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"publisher","award":["RSA6080085"],"award-info":[{"award-number":["RSA6080085"]}],"id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.bioorg.2020.103732","type":"journal-article","created":{"date-parts":[[2020,3,8]],"date-time":"2020-03-08T13:19:35Z","timestamp":1583673575000},"page":"103732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Synthesis of neocryptolepines and carbocycle-fused quinolines and evaluation of their anticancer and antiplasmodial activities"],"prefix":"10.1016","volume":"98","author":[{"given":"Bhornrawin","family":"Akkachairin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warabhorn","family":"Rodphon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onrapak","family":"Reamtong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathirut","family":"Mungthin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumreang","family":"Tummatorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charnsak","family":"Thongsornkleeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somsak","family":"Ruchirawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2018","key":"10.1016\/j.bioorg.2020.103732_b0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2020.103732_b0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev.en.40.010195.001211","article-title":"Malaria: current and future prospects for control","volume":"40","author":"Collins","year":"1995","journal-title":"Annu. Rev. Entomol."},{"key":"10.1016\/j.bioorg.2020.103732_b0015","unstructured":"World Malaria Report, World Health Organization, WHO press, Geneva, Switzerland, 2018."},{"key":"10.1016\/j.bioorg.2020.103732_b0020","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2020.103732_b0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/138955708783744092","article-title":"Malaria combination therapies: advantages and shortcomings","volume":"8","author":"Martinelli","year":"2008","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103732_b0030","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.pt.2008.09.005","article-title":"Recent highlights in antimalarial drug resistance and chemotherapy research","volume":"24","author":"Fidock","year":"2008","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.bioorg.2020.103732_b0035","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/17460441.2017.1319357","article-title":"An overview of quinoline as a privileged scaffold in cancer drug discovery","volume":"12","author":"Musiol","year":"2017","journal-title":"Expert. Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2020.103732_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsps.2012.03.002","article-title":"Quinoline: A versatile heterocyclic","volume":"21","author":"Marella","year":"2013","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.bioorg.2020.103732_b0045","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/j.ejmech.2010.04.011","article-title":"Quinolines and structurally related heterocycles as antimalarials","volume":"45","author":"Kaur","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103732_b0050","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/archderm.1980.01640290097026","article-title":"Antimalarial agents: chloroquine, hydroxychloroquine, and quinacrine","volume":"116","author":"Tanenbaum","year":"1980","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.bioorg.2020.103732_b0055","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.ejmech.2014.07.044","article-title":"A review on anticancer potential of bioactive heterocycle quinoline","volume":"97","author":"Afzal","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103732_b0060","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1016\/j.arabjc.2016.10.009","article-title":"Comprehensive review on current developments of quinoline-based anticancer agents","volume":"12","author":"Jain","year":"2019","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bioorg.2020.103732_b0065","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1021\/ed1003806","article-title":"A graphical journey of innovative organic architectures that have improved our lives","volume":"87","author":"McGrath","year":"2010","journal-title":"J. Chem. Educ."},{"key":"10.1016\/j.bioorg.2020.103732_b0070","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1248\/cpb.38.3048","article-title":"Synthesis and antitumor activity of fused quinoline derivatives","volume":"38","author":"Yanato","year":"1990","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.bioorg.2020.103732_b0075","first-page":"641","article-title":"Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins","volume":"8","author":"Garcia-Carbonero","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2020.103732_b0080","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2165\/11591720-000000000-00000","article-title":"Management strategies for recurrent platinum-resistant ovarian cancer","volume":"71","author":"Naumann","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2020.103732_b0085","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1749-6632.1996.tb26385.x","article-title":"Clinical pharmacology and pharmacodynamics of irinotecan","volume":"803","author":"Chabot","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bioorg.2020.103732_b0090","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/0959-8049(95)00212-2","article-title":"CPT-11 (Irinotecan) in the treatment of colorectal cancer","volume":"31","author":"Armand","year":"1995","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bioorg.2020.103732_b0095","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jhet.5570330204","article-title":"Two new indoloquinoline alkaloids from cryptolepis sanguinolenta: Cryptosanguinolentine and cryptotackieine","volume":"33","author":"Sharaf","year":"1996","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.bioorg.2020.103732_b0100","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/0040-4039(96)00112-8","article-title":"New alkaloids from Cryptolepis sanguinolenta","volume":"37","author":"Cimanga","year":"1996","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2020.103732_b0105","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1021\/np0496284","article-title":"Isoneocryptolepine, a synthetic indoloquinoline alkaloid, as an antiplasmodial lead compound","volume":"68","author":"Van Miert","year":"2005","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2020.103732_b0110","unstructured":"G. Boye, O. Ampofo, Clinical uses of Cryptolepis sanguinolenta, in: Proceedings of the First International Seminar on Cryptolepine, University of Science and Technology, Kumasi, Ghana, 1983, pp. 37\u201340."},{"key":"10.1016\/j.bioorg.2020.103732_b0115","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1021\/jm9704816","article-title":"Ethnobotanical-directed discovery of the antihyperglycemic properties of cryptolepine: its isolation from Cryptolepis sanguinolenta, synthesis, and in vitro and in vivo activities","volume":"41","author":"Bierer","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103732_b0120","series-title":"New antimicrobials of plant origin, Perspectives on new crops and new uses","first-page":"457","author":"Iwu","year":"1999"},{"key":"10.1016\/j.bioorg.2020.103732_b0125","doi-asserted-by":"crossref","unstructured":"A.A. Appiah, The golden roots of Cryptolepis sanguinolenta, in: ACS symposium series, Oxford University Press, 2009, pp. 231\u2013239.","DOI":"10.1021\/bk-2009-1021.ch013"},{"key":"10.1016\/j.bioorg.2020.103732_b0130","doi-asserted-by":"crossref","first-page":"7979","DOI":"10.1002\/ejoc.201402910","article-title":"Neocryptolepine (Cryprotackieine), A unique bioactive natural product: isolation, synthesis, and profile of its biological activity","volume":"2014","author":"Bracca","year":"2014","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.bioorg.2020.103732_b0135","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1021\/jm011102i","article-title":"Synthesis, cytotoxicity, and antiplasmodial and antitrypanosomal activity of new neocryptolepine derivatives","volume":"45","author":"Jonckers","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103732_b0140","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.2174\/092986710791698521","article-title":"Indoloquinolines as scaffolds for drug discovery","volume":"17","author":"Lavrado","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103732_b0145","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0968-0896(01)00401-1","article-title":"Substituted indoloquinolines as new antifungal agents","volume":"10","author":"Ablordeppey","year":"2002","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103732_b0150","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.exppara.2004.08.006","article-title":"In vitro inhibition of \u03b2-haematin formation, DNA interactions, antiplasmodial activity, and cytotoxicity of synthetic neocryptolepine derivatives","volume":"108","author":"Van Miert","year":"2004","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.bioorg.2020.103732_b0155","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1021\/bi972927q","article-title":"The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma cells","volume":"37","author":"Bonjean","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2020.103732_b0160","first-page":"191","article-title":"DNA intercalation, topoisomerase II inhibition and cytotoxic activity of the plant alkaloid neocryptolepine","volume":"15","author":"Bailly","year":"2000","journal-title":"Anti-cancer Drug Des."},{"key":"10.1016\/j.bioorg.2020.103732_b0165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-2999(00)00805-0","article-title":"Bailly, Cytotoxicity and cell cycle effects of the plant alkaloids cryptolepine and neocryptolepine: relation to drug-induced apoptosis","volume":"409","author":"Dassonneville","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2020.103732_b0170","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejmech.2015.02.047","article-title":"Synthesis of isocryptolepine analogs and their structure\u2013activity relationship studies as antiplasmodial and antiproliferative agents","volume":"94","author":"Aroonkit","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103732_b0175","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.1016\/j.tet.2012.04.014","article-title":"Acid-promoted rearrangement of arylmethyl azides: applications toward the synthesis of N-arylmethyl arenes and polycyclic heteroaromatic compounds","volume":"68","author":"Tummatorn","year":"2012","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2020.103732_b0180","doi-asserted-by":"crossref","first-page":"11254","DOI":"10.1021\/acs.joc.8b01851","article-title":"Domino N2-extrusion\u2013cyclization of alkynylarylketone derivatives for the synthesis of indoloquinolines and carbocycle-fused quinolines","volume":"83","author":"Akkachairin","year":"2018","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2020.103732_b0185","first-page":"699","article-title":"Inhibition of eukaryotic DNA topoisomerase I and II activities by indoloquinolinedione derivatives","volume":"40","author":"Riou","year":"1991","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bioorg.2020.103732_b0190","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1021\/bi972927q","article-title":"The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma cells","volume":"37","author":"Bonjean","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2020.103732_b0195","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.exppara.2004.08.006","article-title":"In vitro inhibition of \u03b2-haematin formation, DNA interactions, antiplasmodial activity, and cytotoxicity of synthetic neocryptolepine derivatives","volume":"108","author":"Mierta","year":"2004","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.bioorg.2020.103732_b0200","doi-asserted-by":"crossref","unstructured":"K. Rujimongkon, M. Mungthin, J. Tummatorn, S. Ampawong, P. Adisakwattana, U. Boonyuen, O. Reamtong, Proteomic analysis of Plasmodium falciparum response to isocryptolepine derivative. PLoS One 14(8), e0220871. https:\/\/doi.org\/10.1371\/journal.pone.0220871.","DOI":"10.1371\/journal.pone.0220871"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820301905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820301905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:57:04Z","timestamp":1758614224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206820301905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":40,"alternative-id":["S0045206820301905"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103732","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of neocryptolepines and carbocycle-fused quinolines and evaluation of their anticancer and antiplasmodial activities","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103732","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103732"}}